LTRN logo

Lantern Pharma (LTRN) Cash From Operations

LTRN Annual CFO

-$14.35 M
-$1.58 M-12.37%

31 December 2023

LTRN Cash From Operations Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

LTRN Quarterly CFO

-$5.58 M
-$391.70 K-7.55%

30 September 2024

LTRN Quarterly CFO Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

LTRN TTM CFO

-$17.23 M
-$1.97 M-12.91%

30 September 2024

LTRN TTM CFO Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

LTRN Cash From Operations Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-12.4%-54.5%-26.4%
3 y3 years-153.8%-19.2%-70.2%
5 y5 years-1028.3%-915.1%-709.6%

LTRN Cash From Operations High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-35.5%at low-173.8%at low-62.6%at low
5 y5-year-574.2%at low-1037.2%at low-709.6%at low
alltimeall time-1028.3%at low-1211.6%at low-3947.6%at low

Lantern Pharma Cash From Operations History

DateAnnualQuarterlyTTM
Sept 2024
-
-$5.58 M(+7.5%)
-$17.23 M(+12.9%)
June 2024
-
-$5.19 M(+69.2%)
-$15.26 M(+11.7%)
Mar 2024
-
-$3.07 M(-9.4%)
-$13.66 M(-4.8%)
Dec 2023
-$14.35 M(+12.4%)
-$3.39 M(-6.3%)
-$14.35 M(+5.3%)
Sept 2023
-
-$3.61 M(+0.6%)
-$13.63 M(-3.0%)
June 2023
-
-$3.59 M(-4.4%)
-$14.06 M(+6.5%)
Mar 2023
-
-$3.76 M(+40.8%)
-$13.20 M(+3.4%)
Dec 2022
-$12.77 M(+20.5%)
-$2.67 M(-33.9%)
-$12.77 M(+5.2%)
Sept 2022
-
-$4.04 M(+47.8%)
-$12.14 M(-5.0%)
June 2022
-
-$2.73 M(-17.9%)
-$12.78 M(+8.6%)
Mar 2022
-
-$3.33 M(+63.2%)
-$11.77 M(+11.2%)
Dec 2021
-$10.59 M
-$2.04 M(-56.5%)
-$10.59 M(+4.7%)
DateAnnualQuarterlyTTM
Sept 2021
-
-$4.68 M(+171.4%)
-$10.12 M(+21.5%)
June 2021
-
-$1.73 M(-19.5%)
-$8.33 M(+17.4%)
Mar 2021
-
-$2.14 M(+36.8%)
-$7.09 M(+25.5%)
Dec 2020
-$5.65 M(+165.6%)
-$1.57 M(-45.7%)
-$5.65 M(+17.9%)
Sept 2020
-
-$2.89 M(+488.6%)
-$4.79 M(+95.4%)
June 2020
-
-$490.90 K(-30.2%)
-$2.45 M(+2.0%)
Mar 2020
-
-$703.00 K(-0.8%)
-$2.41 M(+13.0%)
Dec 2019
-$2.13 M(+67.4%)
-$708.90 K(+28.9%)
-$2.13 M(+50.0%)
Sept 2019
-
-$549.90 K(+24.0%)
-$1.42 M(+63.3%)
June 2019
-
-$443.50 K(+4.2%)
-$869.10 K(+104.2%)
Mar 2019
-
-$425.60 K
-$425.60 K
Dec 2018
-$1.27 M
-
-

FAQ

  • What is Lantern Pharma annual cash flow from operations?
  • What is the all time high annual CFO for Lantern Pharma?
  • What is Lantern Pharma annual CFO year-on-year change?
  • What is Lantern Pharma quarterly cash flow from operations?
  • What is the all time high quarterly CFO for Lantern Pharma?
  • What is Lantern Pharma quarterly CFO year-on-year change?
  • What is Lantern Pharma TTM cash flow from operations?
  • What is the all time high TTM CFO for Lantern Pharma?
  • What is Lantern Pharma TTM CFO year-on-year change?

What is Lantern Pharma annual cash flow from operations?

The current annual CFO of LTRN is -$14.35 M

What is the all time high annual CFO for Lantern Pharma?

Lantern Pharma all-time high annual cash flow from operations is -$1.27 M

What is Lantern Pharma annual CFO year-on-year change?

Over the past year, LTRN annual cash flow from operations has changed by -$1.58 M (-12.37%)

What is Lantern Pharma quarterly cash flow from operations?

The current quarterly CFO of LTRN is -$5.58 M

What is the all time high quarterly CFO for Lantern Pharma?

Lantern Pharma all-time high quarterly cash flow from operations is -$425.60 K

What is Lantern Pharma quarterly CFO year-on-year change?

Over the past year, LTRN quarterly cash flow from operations has changed by -$1.97 M (-54.54%)

What is Lantern Pharma TTM cash flow from operations?

The current TTM CFO of LTRN is -$17.23 M

What is the all time high TTM CFO for Lantern Pharma?

Lantern Pharma all-time high TTM cash flow from operations is -$425.60 K

What is Lantern Pharma TTM CFO year-on-year change?

Over the past year, LTRN TTM cash flow from operations has changed by -$3.60 M (-26.39%)